IDEX Corporation reported strong second-quarter 2025 results with record sales of $865.4 million, a 7% increase year-over-year, and adjusted diluted EPS of $2.07, which was relatively flat but exceeded expectations. The company experienced a slight downshift in rapid-turn business orders and a more cautious stance from customers on larger orders, leading to a revised full-year EPS outlook. Despite near-term volatility, IDEX remains confident in its long-term value creation strategy.
Record sales reached $865.4 million, marking a 7% increase year-over-year and 1% organically.
Adjusted diluted EPS was $2.07, remaining relatively flat compared to the prior year but surpassing second-quarter expectations.
Orders increased by 7% to $829.8 million, with organic growth of 2%, though this was below the year-to-date average.
Full-year GAAP diluted EPS guidance was revised to $6.30 - $6.44, and adjusted diluted EPS to $7.85 - $7.95, reflecting a reset of financial assumptions for the remainder of 2025.
IDEX revised its full-year 2025 GAAP diluted EPS outlook to $6.30 - $6.44 and adjusted diluted EPS to $7.85 - $7.95, based on an expected full-year organic sales growth of approximately 1%. For the third quarter 2025, the company anticipates GAAP diluted EPS of $1.54 - $1.61 and adjusted diluted EPS of $1.90 - $1.95, with organic sales growth projected between 2% to 3%.
Visualization of income flow from segment revenue to net income